Anmixtureofthecerebralcirculationischemicstrokeinpatientswithneurologicaldeficitandclinicaleffectsoflivingscoreanalysis[Abstract]circulationbyobservingthesafetyofthehospitalpreparationmixtureonischemiccerebralstrokeinpatientswithqideficiencyandbloodstasistypeofneurologicaldeficitandtheimpactoflivingscore,concluded:circulationAnnmixtureallowsthepatient’sbrainneurologicaldeficitreducedlifeskillsscoresimproved,andmoreeffectivethanstepNaoxintongcapsule,worthyofpromotion.[Keywords:]Ancerebralcirculationmixtureneurologicaldeficitofischemicstroke1GeneralInformationAllpatientsfromMarch2009-March2011Ioutpatientandinpatient,aged45to75years,atotalof62cases,thecontrolgroup31cases,treatmentof31patients,removalofincompleteinformation,accordingtothespecifiedmedicationin2cases,theremaining60cases,34malesand26females,ofwhichthetreatment1group16malesand15females,theoldest70yearsold,minimum45years,controlgroup15malesand14females,agemaximum69yearsold,minimum45-year-oldtwogroupsofpatientsbygenderx2age,diseaseduration,t-testtherewasnosignificantdifferencebetweencomparable.2ObjectSelection2.1Westerndiagnosticcriteria(1normalincidenceinaquietstate(2mostoftheincidenceofheadacheandvomitingwithoutobvious(3)theincidenceofslow,gradualprogressandmore,orstagewascarriedoutmorewithcerebralatherosclerosisrelatedalsobefoundinarterialinflammation,blooddiseases,etc.(4generally1to2daysafteronsetofclearconsciousnessormilddisorder(5withcarotidarterysystemand/orvertebrobasilarsymptomsandsigns(6headCTorMRICheck(7lumbarpunctureshouldgenerallynotbloodinthecerebrospinalfluid.2.2includedinthestandardcasewheretheageof45to75yearsold,maleorfemale,cerebralinfarctionin6hoursto1month.Firstattackorstrokebutdidnot2staypastneurologicaldefect.NeurologicaldeficitscorebyIn1995,cerebrovasculardiseasedevelopedbytheConferencemarkingthe10to45minuteswere.TCMisQiandbloodstasis.2.3exclusioncriteriaofcases(1)hairoftransientcerebralischemia,lacunarinfarction,cerebralembolism,(2fromthebraintumor,braintrauma,brainparasites,metabolicdisorders,rheumaticheartdisease,coronaryheartdiseaseandotherheartpatientswithatrialfibrillationcausedbycerebralembolism,(3)examinationconfirmedthecerebralhemorrhage,(4)pregnancyorbreast-feedingwomen,thosewhoareallergictothedrugcomponent,(5aged75yearsand45yearsofagepatients,associatedwithliver,kidney,hematopoieticsystemandtheendocrinesystemandotherseriousprimarydiseaseandthementallyill.2.4caseseliminate,lossandthestandardsuspensiontest2.4.1andremovedoffthestandardcase(1doesnotmeettheinclusioncriteria,orfailsdrugtestprogramprovidedthecasesshouldbeexcluded(2cases3includedseriousadverseevents,complications,testsshouldnotcontinuetoacceptitsownexitorcompletedaffecttheentirecourseoftreatmenttodeterminetheefficacyorsafetyofpatients,shallbedeemedtofalloff.2.4.2discontinuationcriteria(1clinicaltrialsofseriousadversereactionsshouldbediscontinuedtest(2seriouscomplicationsorrapiddeteriorationshouldbediscontinued.Linkstofreedownloadhttp://eng.hi138.com3treatment3.1Methodsbaseddrugtherapy:twoareusedinthebasictreatmentofseverecases,bedrest,keepquiet,maintainwaterandelectrolyte,acid-basebalanceandgeneralsupportivetherapyforheartfailurepatientstocardiac,diuretictreatment,infectionweretobeeffectiveantibiotics,bloodpressureistoohightoantihypertensivetreatment,noexperimentaldrugssimilartotraditionalChinesemedicine,nutrition,metab...